Some studies have reported that HSPH1 is highly expressed in a variety of cancers, including digestive tract tumours, head and neck tumours and haematological tumours, while it is less expressed in normal tissues, and that the expression of HSPH1 is significantly correlated with the clinical stage and prognosis of a variety of cancers (8–13). This evidence concerns the gene HSPH1 and cancer.